WO2003076578A3 - Polypeptides therapeutiques, acides nucleiques codant pour eux et leur procede d'utilisation - Google Patents

Polypeptides therapeutiques, acides nucleiques codant pour eux et leur procede d'utilisation Download PDF

Info

Publication number
WO2003076578A3
WO2003076578A3 PCT/US2003/006794 US0306794W WO03076578A3 WO 2003076578 A3 WO2003076578 A3 WO 2003076578A3 US 0306794 W US0306794 W US 0306794W WO 03076578 A3 WO03076578 A3 WO 03076578A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
nucleic acids
acids encoding
encoding same
therapeutic polypeptides
Prior art date
Application number
PCT/US2003/006794
Other languages
English (en)
Other versions
WO2003076578A2 (fr
Inventor
John P Ii Alsobrook
David W Anderson
Ferenc L Boldog
Catherine E Burgess
Amitabha Chaudhuri
Steven D Colman
Shlomit R Edinger
Seth Ettenberg
Esha A Gangolli
Valerie L Gerlach
Linda Gorman
Xiaojia Guo
Ramesh Kekuda
Li Li
Timothy Maclachlan
Uriel M Malyankar
Peter S Mezes
Charles E Miller
Isabelle Millet
Muralidhara Padigaru
Meera Patturajan
John Peyman
Xiazhong Qian
Luca Rastelli
Daniel K Rieger
Glennda Smithson
Kimberly A Spytek
David J Stone
Sujatha Sukumaran
Corine A M Vernet
Edward Z Voss
Mei Zhong
Original Assignee
Curagen Corp
John P Ii Alsobrook
David W Anderson
Ferenc L Boldog
Catherine E Burgess
Amitabha Chaudhuri
Steven D Colman
Shlomit R Edinger
Seth Ettenberg
Esha A Gangolli
Valerie L Gerlach
Linda Gorman
Xiaojia Guo
Ramesh Kekuda
Li Li
Timothy Maclachlan
Uriel M Malyankar
Peter S Mezes
Charles E Miller
Isabelle Millet
Muralidhara Padigaru
Meera Patturajan
John Peyman
Xiazhong Qian
Luca Rastelli
Daniel K Rieger
Glennda Smithson
Kimberly A Spytek
David J Stone
Sujatha Sukumaran
Corine A M Vernet
Edward Z Voss
Mei Zhong
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2002/007288 external-priority patent/WO2002072771A2/fr
Application filed by Curagen Corp, John P Ii Alsobrook, David W Anderson, Ferenc L Boldog, Catherine E Burgess, Amitabha Chaudhuri, Steven D Colman, Shlomit R Edinger, Seth Ettenberg, Esha A Gangolli, Valerie L Gerlach, Linda Gorman, Xiaojia Guo, Ramesh Kekuda, Li Li, Timothy Maclachlan, Uriel M Malyankar, Peter S Mezes, Charles E Miller, Isabelle Millet, Muralidhara Padigaru, Meera Patturajan, John Peyman, Xiazhong Qian, Luca Rastelli, Daniel K Rieger, Glennda Smithson, Kimberly A Spytek, David J Stone, Sujatha Sukumaran, Corine A M Vernet, Edward Z Voss, Mei Zhong filed Critical Curagen Corp
Priority to EP03726032A priority Critical patent/EP1572922A2/fr
Priority to AU2003228284A priority patent/AU2003228284A1/en
Priority to CA002478032A priority patent/CA2478032A1/fr
Priority to JP2003574785A priority patent/JP2006501813A/ja
Publication of WO2003076578A2 publication Critical patent/WO2003076578A2/fr
Publication of WO2003076578A3 publication Critical patent/WO2003076578A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

L'invention porte sur de nouveaux polypeptides et les acides nucléiques codant pour eux présentant des propriétés relatives à la stimulation de réponses biochimiques et physiologiques dans une cellule, un tissu, un organe ou un organisme. Ces nouveaux polypeptides sont plus particulièrement des produits géniques de nouveaux gènes ou de leurs fragments ou dérivés biologiquement actifs spécifiés. Les procédés d'utilisation englobent des procédures d'essais diagnostiques et pronostiques et des méthodes de traitement de différents états pathologiques.
PCT/US2003/006794 2002-03-06 2003-03-06 Polypeptides therapeutiques, acides nucleiques codant pour eux et leur procede d'utilisation WO2003076578A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP03726032A EP1572922A2 (fr) 2002-03-06 2003-03-06 Polypeptides therapeutiques, acides nucleiques codant pour eux et leur procede d'utilisation
AU2003228284A AU2003228284A1 (en) 2002-03-06 2003-03-06 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
CA002478032A CA2478032A1 (fr) 2002-03-06 2003-03-06 Polypeptides therapeutiques, acides nucleiques codant pour eux et leur procede d'utilisation
JP2003574785A JP2006501813A (ja) 2002-03-06 2003-03-06 治療ポリペプチド、それをコードする核酸、および使用方法

Applications Claiming Priority (38)

Application Number Priority Date Filing Date Title
US36197402P 2002-03-06 2002-03-06
US60/361,974 2002-03-06
PCT/US2002/007288 WO2002072771A2 (fr) 2001-03-08 2002-03-08 Nouveaux anticorps se liant a des polypeptides antigeniques, acides nucleiques codant pour les antigenes et procedes d'utilisation
US10/093,463 US20030208039A1 (en) 2001-03-08 2002-03-08 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
US10/093,463 2002-03-08
USPCT/US02/07288 2002-03-08
US36503402P 2002-03-15 2002-03-15
US60/365,034 2002-03-15
US36547702P 2002-03-19 2002-03-19
US60/365,477 2002-03-19
US36588402P 2002-03-20 2002-03-20
US36598402P 2002-03-20 2002-03-20
US36598502P 2002-03-20 2002-03-20
US60/365,984 2002-03-20
US60/365,884 2002-03-20
US60/365,985 2002-03-20
US36692802P 2002-03-22 2002-03-22
US60/366,928 2002-03-22
US37201802P 2002-04-12 2002-04-12
US37202202P 2002-04-12 2002-04-12
US60/372,018 2002-04-12
US60/372,022 2002-04-12
US37468202P 2002-04-23 2002-04-23
US60/374,682 2002-04-23
US38809602P 2002-06-12 2002-06-12
US60/388,096 2002-06-12
US38914302P 2002-06-14 2002-06-14
US60/389,143 2002-06-14
US39177902P 2002-06-26 2002-06-26
US60/391,779 2002-06-26
US40374302P 2002-08-15 2002-08-15
US60/403,743 2002-08-15
US41075502P 2002-09-13 2002-09-13
US60/410,755 2002-09-13
US41295702P 2002-09-23 2002-09-23
US60/412,957 2002-09-23
US42038202P 2002-10-22 2002-10-22
US60/420,382 2002-10-22

Publications (2)

Publication Number Publication Date
WO2003076578A2 WO2003076578A2 (fr) 2003-09-18
WO2003076578A3 true WO2003076578A3 (fr) 2006-09-28

Family

ID=27809011

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/006794 WO2003076578A2 (fr) 2002-03-06 2003-03-06 Polypeptides therapeutiques, acides nucleiques codant pour eux et leur procede d'utilisation

Country Status (3)

Country Link
EP (1) EP1572922A2 (fr)
JP (1) JP2006501813A (fr)
WO (1) WO2003076578A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1627666B1 (fr) * 2004-05-22 2007-05-09 KPSS-Kao Professional Salon Services GmbH Composition de teinture de fibres kératiniques
EP1632218B1 (fr) * 2004-05-22 2007-05-09 KPSS-Kao Professional Salon Services GmbH Composition de teinture de fibres kératiniques
WO2006055704A2 (fr) * 2004-11-17 2006-05-26 Curagen Corporation Anticorps diriges contre des proteines ten-m et utilisations associees
JPWO2006062135A1 (ja) * 2004-12-07 2008-06-12 独立行政法人理化学研究所 精神疾患の診断薬
WO2006116681A2 (fr) * 2005-04-28 2006-11-02 Caprion Pharmaceuticals, Inc. Tat-003 et procedes de determination et de traitement du cancer
US8563514B2 (en) * 2007-08-15 2013-10-22 Metamorefix Peptides and pharmaceutical compositions for treating connective tissue
US20110275573A1 (en) * 2008-11-03 2011-11-10 Metamorefix Ltd. Tissue adhesive
US20120058956A1 (en) * 2009-03-03 2012-03-08 Metamorefix Ltd. Peptides derived from ficolin as surfactants

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE GENEMBL [online] KASAHARA M. ET AL.: "CLoning and mapping of a testis-specific gene with sequence similarity to a sperm-coating glycoprotein gene", XP003002331, Database accession no. (M25532) *
DATABASE UNIPROT [online] KASAHARA M. ET AL.: "Cloning and mapping of a testis-specific gene with sequence similarity to a sperm-coating glycoprotein gene", XP003001984, Database accession no. (P16562) *
GENOMICS, vol. 5, no. 3, 1989, pages 527 - 534 *
KASAHARA ET AL.: "Cloning and mapping of a testis-specific gene with sequence similarity to a sperm-coating glycoprotein gene", GENOMICS, vol. 5, no. 3, 1989, pages 527 - 534, XP008070649 *
KRAETZSCHMAR J. ET AL.: "The human cysteine-rich secretory protein (CRISP) family, primary structure and tissue distribution of CRISP-1, CRISP-2 and CRISP-3", EUR. J. BIOCHEM., vol. 236, 1996, pages 827 - 836, XP000997999 *

Also Published As

Publication number Publication date
WO2003076578A2 (fr) 2003-09-18
JP2006501813A (ja) 2006-01-19
EP1572922A2 (fr) 2005-09-14

Similar Documents

Publication Publication Date Title
WO2003031572A3 (fr) Polypeptides therapeutiques, acides nucleiques codant ces derniers et methodes d'utilisation
HUP0500054A2 (hu) Tumorjelző enzimek azonosítására szolgáló eljárás
WO1997045541A3 (fr) Genes en pieces et utilisation de ces genes
WO1995025171A3 (fr) Sequences d'adn pour metalloproteases matricielles, leur production et leur utilisation
WO2003076578A3 (fr) Polypeptides therapeutiques, acides nucleiques codant pour eux et leur procede d'utilisation
WO2001071357A3 (fr) Proteines, genes et leur utilisation pour diagnostiquer et traiter le cancer de la poitrine
WO2004050907A3 (fr) Technique de determination de predisposition a une manifestation de maladies associees au systeme immunitaire
WO2004018633A3 (fr) Acides nucleiques et proteines abca13 : utilisations
HRP20020093A2 (en) Polymorphisms in the human mdr-1 gene and their use in diagnostic and therapeutic applications
WO2000008157A3 (fr) Genes humains transporteurs d'anions atnov
WO2003076610A3 (fr) Variants de kallikrein-2 et kallikrein-3 humaines et leurs utilisations
WO2004013313A3 (fr) Acides nucleiques antisens
WO2003068921A3 (fr) Polypeptides therapeutiques, acides nucleiques codants pour ceux-ci et techniques d'utilisation
EP1277843A3 (fr) Nouveaux gènes humains et leurs produits d'expression liés au cancer du colon
WO2004053075A3 (fr) Compositions, variants d'epissage et procedes relatifs a des genes et des proteines specifiques du sein
WO2004072263A3 (fr) Acide nucleique et proteine correspondante dite 158p1d7, utiles pour le traitement et la detection de cancers de la vessie et autres
WO2005110460A3 (fr) Méthodes de traitement et diagnostics relatifs au vieillissement, particulièrement celui des muscles (14.1)
CY1110911T1 (el) Ανθρωπινο γονιδιο tsc403
WO2004013311A3 (fr) Compositions et methodes se rapportant a des genes et proteines specifiques de l'ovaire
WO2001049879A3 (fr) Expression genique et etats biologiques
EP1494031A3 (fr) Nouveaux gènes humains et leurs produits d'expression
WO2005014804A3 (fr) Protease specifique a l'ubiquitine
WO2004020582A3 (fr) Genes mammiferes impliques dans la resistance a la rapamycine et la tumorigenese designes sous le nom de genes rapr6
WO2003059148A3 (fr) Profils d'expression genique dans le cancer de l'estomac
WO2006034007A3 (fr) Procedes permettant de traiter des troubles metaboliqes par la modulation de la serine/threonine kinase 2 inductible par des sels

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003228284

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2478032

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2003574785

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2003726032

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2003726032

Country of ref document: EP

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)